Divine Skin Secures Exclusive Rights to Nutra Origin Nutraceutical Supplements Line Further Expanding Into $176 Billion Market

MIAMI BEACH, Fla., Nov. 13, 2012 (GLOBE NEWSWIRE) -- Divine Skin Inc., (OTCBB: DSKX) a leading developer and formulator of personal care products, today announced that through its wholly owned subsidiary Nutra Origin, Inc., it has exclusively licensed the line of nutraceuticals and related intellectual property primarily under the brand "Nutra Origin" from LBK Group for a period of ten years. The line includes 60 SKUs in the supplement segment and is distributed through United Natural Foods, a leading national distributor of natural and organic foods and products, as well as being sold on www.nutraorigin.com and through other online retailers.

This exclusive ten year license marks Divine Skin's broader commitment to the large and growing nutraceutical market. According to BCC Research the global market for nutraceutical products was approximately $124 billion in 2008 and is projected to reach $176 billion by 2013.

About Divine Skin

Divine Skin Inc. leads in the development of biotechnology for topical, nutritional, and pharmaceutical therapies. It markets worldwide through online and specialty retailers, cosmetics wholesalers, salons, and medical offices. The fast-growing company went public in 2009.

DS Laboratories, its flagship brand, offers high-performance topical solutions to restore growth and radiance to hair, suppress dandruff and unwanted hair, control acne, improve hygiene, and reduce cellulite and wrinkles. Bioavailability is enhanced through Nanosome encapsulation (www.DSLaboratories.com).

The Sigma Skin brand sells through upscale retailers like Neiman Marcus in the United States and Harvey Nichols in the United Kingdom. The topical products address hair loss and other signs of aging. (www.SigmaSkin.com).

Polaris Research Laboratories makes high-potency minoxidil-based hair-growth formulas (PolarisResearchLabs.com).

The Pure Guild offers purity with performance: Botanical compounds proven effective in clinical trials are extracted without industrial solvents or damaging heat and are sold through premium retailers (ThePureGuild.com).

Forward-Looking Statements:

Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov.

CONTACT: Abner Silva Investor Relations. Divine Skin Inc. 1.407.342.4112 investors@divineskin.com Source:Divine Skin Inc.